Clinical Trial Indicates AI May Improve Breast Cancer Detection in Routine Screenings
A clinical trial suggests that artificial intelligence could assist medical professionals in identifying difficult-to-detect breast cancer signs during standard screenings. Current methods sometimes miss tumors, which are later diagnosed as interval cancers and tend to be more aggressive than those found through screening. The research highlights AI's potential to enhance early detection and improve patient outcomes.
Key facts
- A clinical trial indicates AI may help detect hard-to-spot breast cancer signs
- Standard screenings can miss tumors later diagnosed as interval cancers
- Interval cancers are often more aggressive than screening-detected disease
- The study focuses on improving routine breast cancer screenings
- AI could aid doctors in early identification of these cancers
Entities
—